Bilateral bipolar electrical carotid sinus stimulation acutely reduced muscle sympathetic nerve activity (MSNA) and blood pressure (BP) in patients with resistant arterial hypertension but is no longer available. The second-generation device utilizes a smaller unilateral unipolar disk electrode to reduce invasiveness while saving battery life. We hypothesized that the second-generation device acutely lowers BP and MSNA in treatment-resistant hypertensive patients.
Eighteen treatment-resistant hypertensive patients (9 women/9 men, 53±11 years, 33±5 kg/m2) on stable medications have been included in the study. We monitored finger and brachial BP, heart rate (HR), and MSNA.
Without stimulation, BP was 165±31/91±18 mmHg, HR was 75±17 bpm, and MSNA was 48±14 bursts/min. Acute stimulation with intensities producing side effects that were tolerable in the short term elicited interindividually variable changes in systolic BP (SBP: −16.9±15.0 mmHg, range: 0.0 to −40.8 mmHg, p=0.002), HR (−3.6±3.6 bpm, p=0.004), and MSNA (−2.0±5.8 bursts/min, p=0.375). Stimulation intensities had to be lowered in 12 patients to avoid side effects at the expense of efficacy (SBP: −6.3±7.0 mmHg, range: 2.8 to −14.5 mmHg, p=0.028; HR: −1.5±2.3 bpm, p=0.078; comparison against responses with side effects). Reductions in diastolic BP and MSNA (total activity) were correlated (r2=0.329, p=0.025).
In our patient cohort, unilateral unipolar electrical baroreflex stimulation acutely lowered BP. However, side effects may limit efficacy. The approach should be tested in a controlled comparative study.